"On behalf of our entire board of directors, we wholeheartedly welcome Terry to his new role as President and CEO of Vizgen," said Vizgen co-founder Dr. David R. Walt. "Terry's technical savvy combined with his demonstrated business acumen in building out product and service offerings on a global scale will benefit Vizgen as the Company enters the next phase of commercial development."
Mr. Lo is an experienced leader at biotechnology firms, most recently as President of Akoya Biosciences. Prior to that, he held executive positions at global biopharma and diagnostic companies including PerkinElmer, Roche, Hologic and Bristol-Myers Squibb.
"I'm excited to take the helm at Vizgen to work together with an incredibly talented team of scientists and innovators to bring an unsurpassed spatial profiling technology to market," said Mr. Lo. "Gene expression with spatial context has now become the new research frontier in unlocking core biological questions, and Vizgen's technology is regarded as a premier solution to gain insight into the molecular underpinnings of health, the progression to disease, and the development of new therapies and vaccines."